Qube Research & Technologies (QRT)’s Orthofix Medical OFIX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,933	Closed	-$175K	–	3957
2025 Q3	$175K	Sell	11,933 -151,259	-93%	-$1.99M	﹤0.01%	2968
2025 Q2	$1.82M	Buy	163,192 +104,778	+179%	+$1.3M	﹤0.01%	2235
2025 Q1	$953K	Buy	58,414 +28,973	+98%	+$509K	﹤0.01%	2291
2024 Q4	$514K	Buy	+29,441	New	+$512K	﹤0.01%	2464
2024 Q1	–	Sell	-56,175	Closed	-$757K	–	4752
2023 Q4	$757K	Buy	+56,175	New	+$660K	﹤0.01%	2075
2023 Q2	–	Sell	-48,754	Closed	-$817K	–	2819
2023 Q1	$817K	Buy	+48,754	New	+$954K	﹤0.01%	1372
2020 Q1	–	Sell	-6,030	Closed	-$278K	–	1493
2019 Q4	$278K	Buy	+6,030	New	+$283K	0.01%	1252

Other funds holding OFIX

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Philosophy Capital Management Alamo, California $2.12B AUM 39.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OFIX Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Orthofix Medical (OFIX) in Q4 2025, closing a stake of 11,933 shares — an estimated $175K sold.

Qube Research & Technologies (QRT) first reported a position in OFIX in Q4 2019 and held it in 7 quarters. The position peaked at $1.82M in Q2 2025. 144 funds tracked by Wall St. Rank hold OFIX as of Q4 2025.

Qube Research & Technologies (QRT) reported no remaining Orthofix Medical position as of Q4 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 11,933 Orthofix Medical shares in Q4 2025, an estimated $175K.
Qube Research & Technologies (QRT) first reported a position in Orthofix Medical in Q4 2019 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s Orthofix Medical position peaked at $1.82M in Q2 2025.
144 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.